China · Delayed Price · Currency is CNY Heren Health Statistics
Total Valuation
Heren Health has a market cap or net worth of CNY 3.11 billion. The enterprise value is 2.66 billion.
| Market Cap | 3.11B |
| Enterprise Value | 2.66B |
Important Dates
The last earnings date was Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Heren Health has 262.56 million shares outstanding. The number of shares has increased by 0.49% in one year.
| Current Share Class | 262.56M |
| Shares Outstanding | 262.56M |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | -3.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 8.71% |
| Float | 146.11M |
Valuation Ratios
The trailing PE ratio is 73.96.
| PE Ratio | 73.96 |
| Forward PE | n/a |
| PS Ratio | 7.18 |
| PB Ratio | 2.65 |
| P/TBV Ratio | 2.95 |
| P/FCF Ratio | 54.71 |
| P/OCF Ratio | 31.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.43, with an EV/FCF ratio of 46.85.
| EV / Earnings | 62.85 |
| EV / Sales | 6.15 |
| EV / EBITDA | 22.43 |
| EV / EBIT | 32.70 |
| EV / FCF | 46.85 |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.49 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.91% and return on invested capital (ROIC) is 12.09%.
| Return on Equity (ROE) | 3.91% |
| Return on Assets (ROA) | 3.57% |
| Return on Invested Capital (ROIC) | 12.09% |
| Return on Capital Employed (ROCE) | 6.93% |
| Weighted Average Cost of Capital (WACC) | 6.40% |
| Revenue Per Employee | 632,566 |
| Profits Per Employee | 61,875 |
| Employee Count | 684 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 7.83 |
Taxes
In the past 12 months, Heren Health has paid 410,684 in taxes.
| Income Tax | 410,684 |
| Effective Tax Rate | 0.91% |
Stock Price Statistics
The stock price has decreased by -2.79% in the last 52 weeks. The beta is 0.39, so Heren Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -2.79% |
| 50-Day Moving Average | 13.07 |
| 200-Day Moving Average | 13.44 |
| Relative Strength Index (RSI) | 43.23 |
| Average Volume (20 Days) | 5,307,727 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Heren Health had revenue of CNY 432.67 million and earned 42.32 million in profits. Earnings per share was 0.16.
| Revenue | 432.67M |
| Gross Profit | 203.28M |
| Operating Income | 81.34M |
| Pretax Income | 45.12M |
| Net Income | 42.32M |
| EBITDA | 113.83M |
| EBIT | 81.34M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 476.45 million in cash and 1.91 million in debt, with a net cash position of 474.54 million or 1.81 per share.
| Cash & Cash Equivalents | 476.45M |
| Total Debt | 1.91M |
| Net Cash | 474.54M |
| Net Cash Per Share | 1.81 |
| Equity (Book Value) | 1.17B |
| Book Value Per Share | 4.35 |
| Working Capital | 877.57M |
Cash Flow
In the last 12 months, operating cash flow was 97.29 million and capital expenditures -40.51 million, giving a free cash flow of 56.77 million.
| Operating Cash Flow | 97.29M |
| Capital Expenditures | -40.51M |
| Depreciation & Amortization | 32.49M |
| Net Borrowing | -65.00M |
| Free Cash Flow | 56.77M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 46.98%, with operating and profit margins of 18.80% and 9.78%.
| Gross Margin | 46.98% |
| Operating Margin | 18.80% |
| Pretax Margin | 10.43% |
| Profit Margin | 9.78% |
| EBITDA Margin | 26.31% |
| EBIT Margin | 18.80% |
| FCF Margin | 13.12% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.67% |
| Buyback Yield | -0.49% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 1.36% |
| FCF Yield | 1.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 16, 2021. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 16, 2021 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |